FDA staff: Women's libido drug has small benefit, safety issues
(Reuters) - A drug to increase sexual desire in women showed a statistically significant benefit, according to a preliminary review by the U.S. Food and Drug Administration, but the agency raised concerns about an increased risk of fainting and falling blood pressure.
"The fundamental question is whether these observed placebo-corrected treatment effects outweigh the risks associated with treatment," the agency said in its review, published on Tuesday.
The risk of fainting can occur with the drug, flibanserin, when taken alone and is amplified when taken with certain other drugs or with alcohol.
The FDA's review comes two days ahead of a meeting of external advisors to the agency who will discuss the drug and recommend whether it should be approved.
(Reporting by Toni Clarke in Washington; Editing by Doina Chiacu)
__________________
The Principle of Least Interest: He who cares least about a relationship, controls it.
If I remember right from the news recently, there are 14 drugs for male enhancement and only one for women. Guess who gets the priority.
Historically, medical research has been focused on men, and things like medication dosages for women and children have been extrapolated (guessed at) based on the findings from use in adult men.
This is stupid, but it's cheap.
I find this interesting though, because MEN would certainly benefit as much as women if a safe, effective drug was on the market to increase women's libido.
__________________
The Principle of Least Interest: He who cares least about a relationship, controls it.
